by country – Page 15 – Retraction Watch

Litigious OSU cancer researcher earns his 10th retraction

Carlo Croce, the prolific cancer researcher at The Ohio State University (OSU) with a penchant for hiring — and then losing — lawyers to sue those who displease him, has lost an 10th paper to retraction.

Croce, who in addition to the 10 retractions also has three expressions of concern and 18 corrections for his work, unsuccessfully sued the New York Times for defamation after the newspaper reported on misconduct allegations against him. He has also sued OSU — also unsuccessfully — to force them to restore him as chair of the Department of Cancer Biology and Genetics.

Apparently, Croce and his co-author thought that a correction to the newly retracted article was necessary because of “improper reuse of text from previous articles.” The journal, however, felt differently.

A German vocabulary lesson: Paper retracted because an “individuelle Heilversuche” is not a clinical trial

by mcmurryjulie

A co-editor of the Journal of Neurology has retracted a 2018 paper he helped write because the way the paper was written misled readers about the nature of the research.

The article, “Menière’s disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline—an observational study,” purported to describe the effects of a combination treatment to reduce the incidence of dizziness in people with Menière’s, a neurologic disorder that affects the inner ear.

The first author of the paper is Michael Strupp, of the Munich Center for Neurosciences at Ludwig-Maximilians-University in Munich. Strupp also is one of a troika of editors in-chief of the Journal of Neurology.

According to the abstract:

Frustrated by a university’s lack of action, a journal retracts

Expression of concern, meet expression of frustration.

Eight months ago, in the wake of skepticism about the data in a 2017 paper it had published, the Obstetrics & Gynecology issued an EoC about the article. At the time, the journal, an official title of the American College of Obstetricians and Gynecologists, said it had contacted the authors’ institution — Menoufia University in Shibin Al Kawm, Egypt — about the article.

Those efforts evidently met with silence. Now the journal has retracted the paper, “Sildenafil citrate therapy for oligohydramnios: a randomized controlled trial,” with a swipe at the school’s apparent lack of interest in the misdeeds of its faculty members:

Researcher loses PhD after investigation finds he faked data

Researchers in Singapore have lost a 2011 paper in Gene Therapy after an institutional investigation found that some of their data had been fabricated by a PhD student on the project.

Most of the authors were affiliated with the Institute of Bioengineering and Nanotechnology, a unit of the Agency for Science, Technology and Research (A*STAR).

The article, “Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors,” purported to show that:

Investigation at Japanese university leads to four retractions

A group of pharmacology researchers in Japan have now lost four papers over concerns about the validity of their data.

The studies come from a group at Kobe Gakuin University, which conducted a misconduct investigation into the articles last year and concluded that 10 papers were affected. (Note: The report is in Japanese and does not identify the person or persons responsible for the deception.)

Among the latest to be retracted is a 2012 article in the Journal of Natural Medicines titled “Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice.”

Four retractions follow misconduct inquiry at U Maryland

The Journal of Virology has retracted three papers, and corrected two others, by a group led by a researcher at the University of Maryland, for problematic images.

The articles, published in 2008 and 2014, describe experiments to assess the immune response to Newcastle disease virus in various animal species. The studies were led by Siba K. Samal, a molecular biologist at the Virginia-Maryland Regional College of Veterinary Medicine at the University of Maryland, in College Park.

The retractions make four for Samal, who also lost a 2015 paper in the Journal of Clinical Microbiology, “Glycoprotein-based enzyme-linked immunosorbent assays for serodiagnosis of infectious laryngotracheitis,” and whose work has been scrutinized on PubPeer for more than four years. The notice for that paper reads:

Letter on vaping science paper earns expression of concern because author made up a degree

Leonard Zelig, meet Zvi Herzig.

The journal Circulation has issued an expression of concern about a 2015 letter, putatively written by Herzig, in which the author poked holes in a review article about e-cigarettes.

According to the EoC, however, Herzig, like Zelig, may be a bit of a chameleon.

Researcher formerly of OSU and Taiwan’s Academia Sinica gets 10-year ban

After a 20-month investigation, Taiwan’s leading science institution has hit a former star cancer researcher with a 10-year ban for research misconduct.

Academia Sinica (AS) said its inquiry found that Ching-shih Chen, formerly a distinguished research fellow at the center, was guilty of fabricating or falsifying data in several of the nearly two dozen papers he’d published while affiliated with the institution from 2014 to 2018. AS said Chen was being directed to retract one of the affected papers and correct three others.

A 2018 article in the Taipei Times quoted an AS official, Henry Sun, saying that Chen, who resigned his post there that year, admitted that his staff had “beautified” his results and that he kept loose reins over this lab.

A paper on cats and female students uses up one of its nine lives

Facing a social media storm, a biology journal has temporarily removed a paper arguing that the proliferation of feral cats around university campuses in China is directly related to the proportion of female students — who evidently are more welcoming than men of the wild felines.

The article, “Where there are girls, there are cats,” appeared in Biological Conservation, launching a withering Tweet storm with, at last count, more than 275 replies. The comments ranged from incredulous to outraged, with at least one user noting that the paper was submitted, revised and accepted within a period of about 10 days.

Fourth retraction for Haruko Obokata, focus of STAP cell scandal, after Harvard investigation

More than five years after Nature retracted two highly suspect papers about what had been described as a major breakthrough in stem cell research, another journal has pulled a paper about the work.

The scandal over so-called STAP stem cells took down more than just a few articles. The case centered on Haruko Obokata, a Japanese researcher who conducted the studies as a post-doc in the Harvard lab of Charles Vacanti. Obokata lost her doctoral thesis from Waseda University in 2015 because it plagiarized from the U.S. National Institutes of Health. She also retracted a paper in Nature Protocols.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: